Compare MYO & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYO | NA |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.8M | 51.9M |
| IPO Year | 2017 | 2021 |
| Metric | MYO | NA |
|---|---|---|
| Price | $1.23 | $1.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.64 | N/A |
| AVG Volume (30 Days) | ★ 247.3K | 20.9K |
| Earning Date | 11-09-2026 | 08-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,000,000,000.00 | N/A |
| Revenue This Year | $11.43 | N/A |
| Revenue Next Year | $12.29 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40814.79 | N/A |
| 52 Week Low | $0.61 | $1.58 |
| 52 Week High | $1.89 | $5.16 |
| Indicator | MYO | NA |
|---|---|---|
| Relative Strength Index (RSI) | 37.29 | 36.72 |
| Support Level | $1.18 | $1.69 |
| Resistance Level | $1.75 | $1.96 |
| Average True Range (ATR) | 0.11 | 0.16 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 6.67 | 12.46 |
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.